Pramipexole 0.75mg

Medical Disclaimer

The information provided on this website, including dosages, is for general informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication.
Pramipexole is a medication primarily used in the treatment of Parkinson’s disease and restless legs syndrome

R1 030.00

Out of stock

Images are for illustrative purposes only

Description

Pramipexole is a medication primarily used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It belongs to a class of drugs called dopamine agonists, which work by stimulating dopamine receptors in the brain. Dopamine is a neurotransmitter that plays a crucial role in controlling movement and muscle coordination.

Here’s how Pramipexole is typically used:

1. **Indications**: Pramipexole is commonly prescribed for the management of Parkinson’s disease, a progressive neurological disorder characterized by tremors, stiffness, slowness of movement, and difficulty with balance and coordination. It is also used to alleviate symptoms of restless legs syndrome, a condition characterized by uncomfortable sensations in the legs and an irresistible urge to move them, particularly at night.

2. **Dosage**: The dosage of Pramipexole may vary depending on the specific condition being treated, the severity of symptoms, and the patient’s response to treatment. It is usually taken orally in the form of tablets or extended-release tablets, with or without food. The dosage is typically started at a low level and gradually increased over time to achieve optimal symptom control while minimizing side effects.

3. **Mechanism of Action**: Pramipexole works by activating dopamine receptors in the brain, particularly dopamine D2 and D3 receptors. By mimicking the action of dopamine, Pramipexole helps to restore dopamine levels in the brain, thereby improving motor function and reducing the symptoms of Parkinson’s disease. In restless legs syndrome, Pramipexole may alleviate symptoms by modulating dopamine activity in the brain.

4. **Duration**: The duration of treatment with Pramipexole may vary depending on the individual’s response to therapy and the progression of the underlying condition. In Parkinson’s disease, Pramipexole is typically used as a long-term treatment to manage symptoms and improve quality of life. In restless legs syndrome, treatment may be ongoing to alleviate symptoms and improve sleep quality.

5. **Monitoring**: Regular monitoring is essential during treatment with Pramipexole to assess the response to therapy, monitor for potential side effects or complications, and adjust the dosage or treatment regimen as needed. Patients may also undergo periodic evaluations of motor function and other relevant parameters.

Common side effects of Pramipexole may include nausea, dizziness, drowsiness, constipation, and hallucinations. More serious side effects, such as orthostatic hypotension (a sudden drop in blood pressure upon standing), impulse control disorders, or worsening of psychiatric symptoms, are rare but possible and should be monitored closely.

In summary, Pramipexole is a medication used in the treatment of Parkinson’s disease and restless legs syndrome by stimulating dopamine receptors in the brain. It is taken orally and works by restoring dopamine levels and improving motor function.

Additional information

Chemical-composition

PD (Parkinson's disease), Treatment for RLS (Restless legs syndrome)

Strength

0.75mg

Pack-size

30 Tabs

Laboratory

Pharmaceuticals

Shopping Cart
Scroll to Top